CDRE trades 56.9% below Wall Street's consensus target of $44.33.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CDRE achieves its forward estimates and maintains a stable P/E multiple of 24.7x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 23, 2026, Cadre Holdings, Inc. (CDRE) has a Wall Street consensus price target of $44.33, based on estimates from 9 covering analysts. With the stock currently trading at $27.56, this represents a potential upside of +56.9%. The company has a market capitalization of $1.18B.
Analyst price targets range from a low of $40.00 to a high of $53.00, representing a 29% spread in expectations. The median target of $40.00 differs from the mean, suggesting potential outlier estimates.
The current analyst consensus rating is Buy, with 6 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, CDRE trades at a trailing P/E of 27.0x and forward P/E of 24.7x. Analysts expect EPS to grow +34.3% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $30.44, with bear and bull scenarios of $19.18 and $40.10 respectively. Model confidence stands at 45/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
AXONAxon Enterprise, Inc. | $33.0B | $410.03 | $652.11 | +54.0% | Buy | 55.1x | 21 |
SWBISmith & Wesson Brands, Inc. | $736M | $16.45 | $16.50 | +2.6% | Buy | 58.5x | 4 |
AOUTAmerican Outdoor Brands, Inc. | $152M | $9.97 | $12.50 | +23.4% | Buy | 69.9x | 5 |
CODICompass Diversified | $777M | $10.33 | $15.00 | +48.4% | Hold | 35.8x | 14 |
MSAMSA Safety Incorporated | $6.4B | $163.95 | $222.33 | +35.2% | Buy | 18.5x | 11 |
AMSFAMERISAFE, Inc. | $590M | $31.40 | $44.50 | +42.1% | Buy | 14.9x | 6 |
GNSSGenasys Inc. | $73M | $1.60 | — | — | — | — | — |
TACTTransAct Technologies Incorporated | $52M | $5.10 | — | — | — | — | — |
DGLYDigital Ally, Inc. | $2M | $1.28 | — | — | — | — | — |
HONHoneywell International Inc. | $144.5B | $228.11 | $249.64 | +9.0% | Buy | 21.8x | 28 |
Quick answers to the most common questions about buying CDRE stock.
The consensus Wall Street price target for CDRE is $44.33, representing 56.9% upside from the current price of $27.56. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CDRE has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 6 Buy/Strong Buy ratings. The consensus 12-month price target of $44.33 implies 56.9% upside from current levels.
CDRE trades at a forward P/E of 24.7373x, representing a moderate valuation. With analysts targeting $44.33 (56.9% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $53 for CDRE, while the most conservative target is $40. The consensus of $44.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $40 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CDRE is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 2 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CDRE stock forecast based on 9 Wall Street analysts shows a consensus price target of $44.33, with estimates ranging from $40 (bear case) to $53 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $30, with bear/bull scenarios of $19/$40.
Our quantitative valuation model calculates CDRE's fair value at $30 (base case), with a bear case of $19 and bull case of $40. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 45/100.
CDRE trades at a forward P/E ratio of 24.7x based on next-twelve-months earnings estimates compared to a trailing P/E of 27.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CDRE, with a "Buy" consensus rating and $44.33 price target (56.9% upside). 6 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CDRE analyst price targets range from $40 to $53, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $44.33 consensus represents the middle ground. Our model's $19-$40 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.